JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99774

Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (HRP)

Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (HRP)

5

(1 Review)

|

(19 Publications)

Suitable for ICC, I-ELISA. Ideal for western blot. Cited in 19 publications.

查看别名

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

1 Images
Indirect ELISA - Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (HRP) (AB99774)
  • I-ELISA

Supplier Data

Indirect ELISA - Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (HRP) (AB99774)

ELISA plate was coated with purified human IgG1, IgG2, IgG3, and IgG4. Immunoglobulins were detected with serially diluted Mouse Anti-Human IgG1 Hinge-HRP. Recommended usage 1/2000 – 1/8000 dilution.

不同偶联物与剂型 (1)

  • Unconjugated

    Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain

关键信息

宿主种属

Mouse

靶标种属

Human

靶标亚型

IgG1

靶标特异性

Heavy chain hinge

最低交叉反应
预吸附

No

偶联物

HRP

激发波长/发射波长
应用

I-ELISA, ICC

applications

克隆

Monoclonal

克隆号

4E3

亚型

IgG1

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "I-ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/2000 - 1/8000", "notes":"<p></p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein G
存储溶液
pH: 7.4 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C

产品实验方案

靶点信息

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

文献 (19)

Recent publications for all applications. Explore the full list and refine your search

British journal of haematology : PubMed40386886

2025

Anti-HSP90α IgG may protect against antiphospholipid syndrome in systemic lupus erythematosus by reducing platelet activation.

Applications

Unspecified application

Species

Unspecified reactive species

Marina Barguil Macêdo,Andreas Jönsen,Anders A Bengtsson,Iva Gunnarsson,Elisabet Svenungsson,Christian Lood

Frontiers in immunology 15:1455454 PubMed39450180

2024

Exploring the naturally acquired response to Pvs47 gametocyte antigen.

Applications

Unspecified application

Species

Unspecified reactive species

Gisele Tatiane Soares da Veiga,Rafael Amaral Donassolo,Sofia Forcellini,Julia Weber Ferraboli,Mario Antonio Kujbida Junior,Líndice Mitie Nisimura,Letícia Werzel Bassai,Rafael Luis Kessler,Mariana Serpeloni,Najara Carneiro Bittencourt,Yanka Evellyn Alves R Salazar,Luiz Felipe Ferreira Guimarães,Jaime Louzada,Dayanne Kamylla Alves da Silva Barros,Stefanie Costa Pinto Lopes,Luzia Helena Carvalho,Tais Nóbrega de Sousa,Flora Satiko Kano,Fabio Trindade Maranhão Costa,Pryscilla Fanini Wowk,Letusa Albrecht

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 19:55 PubMed37386541

2023

No impact of helminth coinfection in patients with smear positive tuberculosis on immunoglobulin levels using a novel method measuring Mycobacterium tuberculosis-specific antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Giggil Pushpamithran,Camilla Skoglund,Fanny Olsson,Melissa Méndez-Aranda,Thomas Schön,Mårten Segelmark,Olle Stendahl,Robert H Gilman,Robert Blomgran

Parasites & vectors 15:387 PubMed36273150

2022

Linear and conformational determinants of visceral leishmaniasis diagnostic antigens rK28 and rK39.

Applications

Unspecified application

Species

Unspecified reactive species

Poppy Simonson,Tapan Bhattacharyya,Sayda El-Safi,Michael A Miles

Infection and immunity 90:e0038221 PubMed34780279

2021

Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon.

Applications

Unspecified application

Species

Unspecified reactive species

Alexander I Ward,Michael D Lewis,Martin C Taylor,John M Kelly

Parasites & vectors 14:543 PubMed34670602

2021

Assessing antibody decline after chemotherapy of early chronic Chagas disease patients.

Applications

Unspecified application

Species

Unspecified reactive species

Niamh Murphy,M Victoria Cardinal,Tapan Bhattacharyya,Gustavo F Enriquez,Natalia P Macchiaverna,Alejandra Alvedro,Héctor Freilij,Pablo Martinez de Salazar,Israel Molina,Pascal Mertens,Quentin Gilleman,Ricardo E Gürtler,Michael A Miles

Viruses 12: PubMed33138336

2020

Association of Genetic Polymorphisms in , , , and with the Clinical Forms of Dengue in Patients from Veracruz, Mexico.

Applications

Unspecified application

Species

Unspecified reactive species

Araceli Posadas-Mondragón,José Leopoldo Aguilar-Faisal,Gerardo Zuñiga,Jonathan Javier Magaña,José Angel Santiago-Cruz,Edith Guillén-Salomón,Verónica Alcántara-Farfán,María Luisa Arellano-Flores,Juan Santiago Salas-Benito,Rocío M Neri-Bazán,Lucero Luna-Rojas,Amanda Marineth Avila-Trejo,Adolfo Chávez-Negrete

PLoS pathogens 16:e1008796 PubMed32913364

2020

A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Yuxin Chen,Xin Tong,Yang Li,Bin Gu,Jiawei Yan,Yong Liu,Han Shen,Rui Huang,Chao Wu

The Journal of biological chemistry 295:12317-12327 PubMed32665404

2020

Structural features of bovine colostral immunoglobulin that confer proteolytic stability in a simulated intestinal fluid.

Applications

Unspecified application

Species

Unspecified reactive species

Randall E Burton,Skaison Kim,Rutvij Patel,Deborah S Hartman,Daniel E Tracey,Barbara S Fox

Arthritis & rheumatology (Hoboken, N.J.) 72:687-693 PubMed31612628

2020

Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Hang Liu,Cory A Perugino,Musie Ghebremichael,Zachary S Wallace,Sydney B Montesi,John H Stone,Shiv Pillai
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com